Skip to main content
. 2016 Mar 15;2016:2596782. doi: 10.1155/2016/2596782

Table 2.

HBV and HCV from the SRP002272 study.

Run ID Sample_Source Reference Cov (%) Depth
SRR039611 Human Normal Liver Tissue NA NA NA
SRR039612 Human Normal Liver Tissue NA NA NA
SRR039613 Human Normal Liver Tissue NA NA NA
SRR039614 HBV-Infected Liver Tissue JQ688405 423 (13.2) 3.0
SRR039615 Severe Chronic Hepatitis B Liver Tissue NA NA NA
SRR039616 HBV(+) Distal Tissue NA NA NA
SRR039617 HBV(+) Adjacent Tissue NA NA NA
SRR039618 HBV(+) Side Tissue NA NA NA
SRR039619 HBV(+) HCC Tissue NA NA NA
SRR039620 HBV(+) Adjacent Tissue JQ688404 1756 (54.6) 6.0
SRR039621 HBV(+) HCC Tissue GQ475344 321 (10) 1.5
SRR039622 HCV(+) Adjacent Tissue D85516 1032 (10.8) 1.8
SRR039623 HCV(+) HCC Tissue GU133617 805 (8.3) 8.0
SRR039624 HBV(−) HCV(−) Adjacent Tissue NA NA NA
SRR039625 HBV(−) HCV(−) HCC Tissue NA NA NA

“Run ID” is uniq for each high-throughput fastq file in the NCBI SRA database. “Reference” uses the NCBI GenBank accession number. “Cov (%)” and “Depth” represent the genome coverage and the average depth, respectively. “Side Tissue” is close to the border between the tumor tissues and the normal tissues but 0–2 cm far from the tumor tissues. “Adjacent Tissue” is the normal tissues 2–5 cm far from the tumor tissues. “Distal Tissue” is the normal tissues at least 10cm far from the tumor tissues. “SRR039619” should have contained HBV but it was not found by our pipeline.